Literature DB >> 9499037

Multiple functions within the Epstein-Barr virus EBNA-3A protein.

I Cludts1, P J Farrell.   

Abstract

Two regions of the EBNA-3A protein of Epstein-Barr virus were shown to be capable of binding to the cell protein RBP-Jk (also known as CBF-1), a component of the Notch signaling pathway. Consistent with this binding, EBNA-3A inhibited reporter gene expression from plasmids containing RBP-Jk DNA binding sites within their promoters, including the Cp promoter. When EBNA-3A was linked to a GAL4 DNA binding domain, it repressed the activity of a promoter containing GAL4 binding sites at all plasmid concentrations tested. However, a deletion mutant of EBNA-3A lacking amino acids 100 to 364 showed a biphasic response in the GAL4 assay: it inhibited transcription at low DNA concentrations but activated it at high DNA concentrations. There appears to be a gene activation function within EBNA-3A that is masked in the full-length protein in this assay. Current models for EBNA-3 function have stressed transcription repression through binding to RBP-Jk, but we consider an alternative scheme in which the role of the binding of EBNA-3A, -3B, and -3C to RBP-Jk is to buffer the levels of active EBNA-3 protein. We have also found that the behavior of EBNA-3A in a cell fractionation procedure that distinguishes insoluble matrix from soluble cell fractions is modified by EBNA-LP, indicating a further novel level of interplay between the EBNA proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499037      PMCID: PMC109476          DOI: 10.1128/JVI.72.3.1862-1869.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Cell growth effects of Epstein-Barr virus leader protein.

Authors:  G J Allan; G J Inman; B D Parker; D T Rowe; P J Farrell
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

2.  BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

Authors:  A Ricksten; B Kallin; H Alexander; J Dillner; R Fåhraeus; G Klein; R Lerner; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

4.  Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5.

Authors:  W Q Jiang; L Szekely; V Wendel-Hansen; N Ringertz; G Klein; A Rosén
Journal:  Exp Cell Res       Date:  1991-12       Impact factor: 3.905

5.  Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

Authors:  C M Rooney; M Brimmell; M Buschle; G Allan; P J Farrell; J L Kolman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels.

Authors:  W Hammerschmidt; B Sugden; V R Baichwal
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins.

Authors:  L Petti; C Sample; E Kieff
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Authors:  L Szekely; K Pokrovskaja; W Q Jiang; H de The; N Ringertz; G Klein
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Transcription regulation by murine B-myb is distinct from that by c-myb.

Authors:  R J Watson; C Robinson; E W Lam
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

10.  Intranuclear distribution of Epstein-Barr virus-encoded nuclear antigens EBNA-1, -2, -3 and -5.

Authors:  W Q Jiang; V Wendel-Hansen; A Lundkvist; N Ringertz; G Klein; A Rosén
Journal:  J Cell Sci       Date:  1991-07       Impact factor: 5.285

View more
  26 in total

1.  Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.

Authors:  H Jiang; Y G Cho; F Wang
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.

Authors:  L C Spender; E J Cannell; M Hollyoake; B Wensing; J M Gawn; M Brimmell; G Packham; P J Farrell
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

Authors:  Adrienne Chen; Bo Zhao; Elliott Kieff; Jon C Aster; Fred Wang
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 4.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.

Authors:  Seiji Maruo; Eric Johannsen; Diego Illanes; Andrew Cooper; Elliott Kieff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Authors:  Sungwook Lee; Shuhei Sakakibara; Seiji Maruo; Bo Zhao; Michael A Calderwood; Amy M Holthaus; Chiou-Yan Lai; Kenzo Takada; Elliott Kieff; Eric Johannsen
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

7.  Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones.

Authors:  Paul Young; Emma Anderton; Kostas Paschos; Rob White; Martin J Allday
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

8.  Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

Authors:  Lenka Skalska; Robert E White; Melanie Franz; Michaela Ruhmann; Martin J Allday
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

9.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

10.  Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Authors:  Marie L Hertle; Claudia Popp; Sabine Petermann; Sabine Maier; Elisabeth Kremmer; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.